Billionaire Israel Englander is Behaving Quite Bullishly

MILLENNIUM MANAGEMENTBillionaire Israel Englander was making an overall bullish statement with equity purchases in 3Q, shaking up his top twenty holdings with various increases and new additions across a variety of industries. Englander founded Millennium Management in 1989 and grew the fund to around $13 billion in AUM by mid-2011.

Three of the most interesting share increases that thrust all of these stocks into Millennium’s top ten holdings included Tyco International Ltd. (NYSE:TYC), Edison International (NYSE:EIX) and Amerigroup Corporation (NYSE:AGP).

Following a 200% increase during 2Q, Millennium increased its Tyco stake 230%, putting the security systems company up from its 43rd largest holding to 1st. Tyco was also Iridian Asset Management’s top stock pick at the end of 3Q. Tyco recently completed the split of its key businesses, now with operations in commercial fire/security and global residential security. Growth is still expected to be relatively low in 2012 and 2013, at 2% and 4% year over year, respectively. The slowing global economy has been Tyco’s biggest headwind, but separation of its businesses should lead to better productivity over the long run. Tyco continues to trade cheaply compared to major competitors; its trailing P/E is 10x, compared to Brink at 16x and GEO Group at 23x.

Edison International was another big increase for Millennium, having upped its 2Q stake 330% to put the utility company as the fund’s 6th largest holding at the end of 3Q, up from 199th at the end of 2Q. EPS is expected to come in down 19% for 2012 compared to 2011, thanks in part to lower realized power prices and higher fuel costs. Edison does pay a 3.0% dividend yield, but this yield is below it utility peers. We see concerns over the outcome of Edison’s Mission Group debt restructuring. If Edison is unable to restructure EMG’s capital structure it may have to divest the segment.

Amerigroup was essentially a new position for Millennium during 3Q, where the firm upped its position over 25,000% to make the managed healthcare company its 8th largest 13F holding. In July, WellPoint announced that it would purchase Amerigroup for $92 per share; the stock currently trades around $91.40. Amerigroup is also a takeover target owned by the Harvard Endowment.

The deal is expected to close in 1Q 2013, but for an investment to be worthwhile to the average investor they would need to be have a meaningful amount of capital to invest. Even without the buyout offer, Amerigroup has promising growth prospects, with revenue expected to be up 40% in 2012 on the back of market expansion. Trading at a premium P/E of 32x due to the buyout offer, the managed healthcare company is now well above its peers and would likely see a pullback if the deal falls apart.

A couple of Millennium’s bearish moves that stood out to us were his general negative plays against pharma, including sales of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Pfizer Inc. (NYSE:PFE). Englander sold off 74% of his 2Q Teva stake during 3Q, taking Teva from the 12th largest holding (2Q) to Englander’s 213st largest holding (3Q). Teva is the generic and branded pharma company that is expected to see relatively flat revenue growth in 2013, compared to an 11% gain in 2012.

Headwinds have put the stock in mixed trading territory of late, which include diminishing generic opportunities and increased global pressures. Even so, Teva is a market leader in the generic drug sales industry, with sales nearly double that of its closest competitor. Given the company already trades in line with many of its competitors on a valuation basis, it would be worthwhile for investors to follow Englander’s bearish sentiment regarding Teva for now.

Pfizer went from Millennium’s 16th largest 13F holding to 161st after a 64% share sell off in 3Q. Pfizer trades on the low end from a P/E perspective, trading at 19x, where Johnson & Johnson trades at 23x, Merck at 20x and Bristol Myers at 29x. Pfizer expects to see an influx of cash next year, which will go to funding its $10 million share repurchase program. The funds will come from an expected IPO worth 20% of its animal health business, and the sale of its nutrition unit to Nestle for over $11 billion in cash. Pfizer also pays a healthy 3.7% dividend yield.

We view the chance that Millennium is taking in Amerigroup, even though there are a number of other funds taking the bet as well, as too risky for individual investors. We are also cautious of Tyco and Edison’s prospects, and would wait to see how their key events play out. We also agree with Millennium’s bearish outlook on Teva, but would consider taking a look at Pfizer. Check out all of Millennium Management’s holdings here.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!